ABOUT THE EXPERT

Rheumatology / Systemic Lupus Erythematosus

expert perspectives

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medic...READ MORE

Rheumatology / Systemic Lupus Erythematosus

clinical topic updates by Bevra H. Hahn, MD

Recent data with belimumab and voclosporin are of interest in the setting of lupus nephritis, a common complication in patients with systemic lupus...READ MORE

Rheumatology / Systemic Lupus Erythematosus

expert roundtables by Bevra H. Hahn, MD; Joan T. Merrill, MD; and George C. Tsokos, MD

Despite significant advances in the understanding of the pathophysiology of systemic lupus erythematosus (SLE), a number of challenges persist. In ...READ MORE

Rheumatology / Systemic Lupus Erythematosus

expert roundtables by Bevra H. Hahn, MD; Joan T. Merrill, MD; and George C. Tsokos, MD

There have been 2 recent additions to the therapeutic landscape in systemic lupus erythematosus (SLE), with voclosporin and belimumab both showing ...READ MORE

Rheumatology / Systemic Lupus Erythematosus

patient care perspectives by Bevra H. Hahn, MD

B-cell–activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS), and a proliferation-inducing ligand (APRIL) are targets of therapeut...READ MORE

Rheumatology / Systemic Lupus Erythematosus

expert roundtables by Bevra H. Hahn, MD; Joan T. Merrill, MD; and George C. Tsokos, MD

Treatment goals in systemic lupus erythematosus (SLE) include achieving long-term patient survival, preventing flares and organ damage, and safegua...READ MORE

Rheumatology / Systemic Lupus Erythematosus

expert roundtables by Bevra H. Hahn, MD; Joan T. Merrill, MD; and George C. Tsokos, MD

Treat-to-target strategies in systemic lupus erythematosus (SLE) involve setting the treatment target to complete remission or to low disease activ...READ MORE